Hayley Flanagan

Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia

Matthew D. Dun, M. Larsen, B. Nixon, 2020, Leukemia.

Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia

Matthew D. Dun, D. Beck, B. Nixon, 2020, Leukemia.

Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors

Matthew D. Dun, L. Ashman, R. Lock, 2016, Oncotarget.

Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia.

Matthew D. Dun, Jonathan C. Morris, M. Dun, 2016, Organic & biomolecular chemistry.